Filing Details
- Accession Number:
- 0001209191-23-055663
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-17 12:36:50
- Reporting Period:
- 2023-11-16
- Accepted Time:
- 2023-11-17 12:36:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 818033 | Heron Therapeutics Inc. | HRTX | Pharmaceutical Preparations (2834) | 942875566 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1488864 | Ira Duarte | 4242 Campus Point Court, Suite 200 San Diego CA 92121 | Evp, Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-11-16 | 85,000 | $0.89 | 85,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The range of purchase prices paid was $0.8708 to $0.9201. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased at each separate price.
Billionaire Hedge Funds
